Literature DB >> 9719673

Chronic and initiation/promotion skin bioassays of petroleum refinery streams.

C M Skisak1, E M Furedi-Machacek, S S Schmitt, M S Swanson, E H Vernot.   

Abstract

Nine refinery streams were tested in both chronic and initiation/promotion (I/P) skin bioassays. In the chronic bioassay, groups of 50 C3H/HeJ mice received twice weekly applications of 50 microl of test article for at least 2 years. In the initiation phase of the I/P bioassay, groups of CD-1 mice received an initiating dose of 50 microl of test article for 5 consecutive days, followed by promotion with 50 microl of phorbol-12-myristate-13-acetate (0.01% w/v in acetone) for 25 weeks. In the promotion phase of the I/P bioassay, CD-1 mice were initiated with 50 microl of 7,12-dimethylbenzanthracene (0.1% w/v in acetone) or acetone, followed by promotion with 50 microl of test article twice weekly for 25 weeks. The most volatile of the streams, sweetened naphtha, and the least volatile, vacuum residuum, were noncarcinogenic in both assays. Middle distillates, with a boiling range of 150 degrees-370 degrees C, demonstrated carcinogenic activity in the chronic bioassay and acted as promoters but not initiators in the I/P bioassay. Untreated mineral oil streams displayed initiating activity and were carcinogenic in the chronic bioassay, presumably due to the presence of polycyclic aromatic hydrocarbons of requisite size and structure. A highly solvent-refined mineral oil stream lacked initiating activity. These results indicate that the I/P bioassay, which takes 6 months to complete, may be a good qualitative predictor of the results of a chronic bioassay, at least for petroleum streams. Furthermore, the I/P bioassay can provide insight into possible mechanisms of tumor development.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 9719673      PMCID: PMC1567246          DOI: 10.1289/ehp.9410282

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  13 in total

1.  Simulation modeling of carcinogenesis.

Authors:  L B Ellwein; S M Cohen
Journal:  Toxicol Appl Pharmacol       Date:  1992-03       Impact factor: 4.219

Review 2.  Cell proliferation in carcinogenesis.

Authors:  S M Cohen; L B Ellwein
Journal:  Science       Date:  1990-08-31       Impact factor: 47.728

3.  The carcinogenic initiating and promoting properties of a lightly refined paraffinic oil.

Authors:  R H McKee; R T Plutnick; R T Przygoda
Journal:  Fundam Appl Toxicol       Date:  1989-05

4.  Skin tumorigenic potential of crude and refined coal liquids and analogous petroleum products.

Authors:  H P Witschi; L H Smith; E L Frome; M E Pequet-Goad; W H Griest; C H Ho; M R Guerin
Journal:  Fundam Appl Toxicol       Date:  1987-08

5.  Carcinogenicity of petroleum lubricating oil distillates: effects of solvent refining, hydroprocessing, and blending.

Authors:  C A Halder; T M Warne; R Q Little; P J Garvin
Journal:  Am J Ind Med       Date:  1984       Impact factor: 2.214

6.  The role of chronic acanthosis and subacute inflammation in tumor promotion in CD-1 mice by petroleum middle distillates.

Authors:  C Skisak
Journal:  Toxicol Appl Pharmacol       Date:  1991-07       Impact factor: 4.219

7.  Dermal carcinogenic activity of petroleum-derived middle distillate fuels.

Authors:  R W Biles; R H McKee; S C Lewis; R A Scala; L R DePass
Journal:  Toxicology       Date:  1988-12-30       Impact factor: 4.221

8.  Tumor initiation and promotion effects of petroleum streams in mouse skin.

Authors:  J M Gerhart; N S Hatoum; C A Halder; T M Warne; S L Schmitt
Journal:  Fundam Appl Toxicol       Date:  1988-07

Review 9.  Overview of tumor promotion in animals.

Authors:  T J Slaga
Journal:  Environ Health Perspect       Date:  1983-04       Impact factor: 9.031

10.  The carcinogenic potential of twelve refined mineral oils following long-term topical application.

Authors:  S M Doak; V K Brown; P F Hunt; J D Smith; F J Roe
Journal:  Br J Cancer       Date:  1983-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.